How to Dose CJC-1295 and Ipamorelin: Research Guide

How to Dose CJC-1295 and Ipamorelin: Research Guide. Research guide to CJC-1295 and Ipamorelin dose math, reconstitution, syringe units, blend vials, and calculator setup. Key Takeaways The dose math starts with vial identity. CJC-1295 with DAC, CJC-1295 No DAC, Ipamorelin, and blended CJC-1295/Ipamorelin vials should not be treated as the same input. U-100 syringe units are volume, not peptide amount. On a U-100 insulin syringe, 100 units equals 1 mL. The mcg amount depends on vial strength and reconstitution volume. Blend vials require extra care. A 10 mg blend may mean 10 mg total, or it may be labeled as separate compound amounts. Always verify the label and COA before calculating. Most mistakes come from mixing up mg, mcg, mL, and units. Convert milligrams to micrograms first, then calculate concentration, then calculate syringe volume. This guide is for research math only. CJC-1295 and Ipamorelin are not FDA-approved medications and PeptideStack does not provide medical dosing instructions. How to dose CJC-1295 and Ipamorelin is really two questions: what research amount is being modeled, and how many syringe units represent that amount after the vial is reconstituted. Those are separate steps. The biological protocol question belongs to a qualified professional and a formal research design; the math question can be handled with vial strength, bacteriostatic water volume, and a U-100 syringe conversion. This guide focuses on the math side: how to read a CJC-1295 + Ipamorelin vial, how to convert mg to mcg, how to understand 1:1 blend examples, and how to use the Peptide Calculator without confusing units for dose. For mechanism differences between the two compounds, start with our CJC-1295 vs Ipamorelin research comparison . For post-mixing handling, use the reconstituted peptide storage guide . Growth-hormone secretagogues like CJC-1295 and Ipamorelin can raise IGF-1 and nudge fasting glucose, so anyone running them should baseline and re-check their bloodwork. Our free peptide cheat sheet helps researchers track the IGF-1, glucose, HbA1c, and hormone markers these compounds influence most. Quick Research Math Example Here is the cleanest way to think about the math. If a blended vial contains 10 mg total peptide and is reconstituted with 2 mL bacteriostatic water, the concentration is 5 mg per mL, or 5,000 mcg per mL. Since a U-100 syringe has 100 units per mL, each syringe unit equals 50 mcg of total blend. If that 10 mg blend is a 1:1 CJC-1295 + Ipamorelin vial, each 50 mcg total unit represents about 25 mcg CJC-1295 and 25 mcg Ipamorelin. In that example, 4 units equals 200 mcg total blend, or about 100 mcg of each compound. This is a calculator example, not a personal dosing recommendation. Step 1: Confirm Which CJC-1295 You Have CJC-1295 can refer to different formats. CJC-1295 No DAC is often discussed as Modified GRF 1-29 and is used in short-pulse research contexts. CJC-1295 with DAC is albumin-binding and has a much longer exposure profile. Those are not interchangeable for timing, protocol interpretation, or research design. Most CJC-1295 + Ipamorelin combo products are marketed around CJC-1295 No DAC, because the shorter GHRH analog is commonly paired with Ipamorelin's GH secretagogue pulse. If the vial label does not clearly say No DAC, DAC, blend ratio, and total milligrams, treat the calculation as incomplete until the supplier documentation is verified. Step 2: Convert Milligrams to Micrograms Peptide vials are usually sold in milligrams, while research amounts are often discussed in micrograms. The conversion is simple: 1 mg equals 1,000 mcg. A 5 mg vial contains 5,000 mcg. A 10 mg vial contains 10,000 mcg. For a blend, the key question is whether that number is the total blend amount or the amount of each compound. For example, a 10 mg total 1:1 blend contains 5 mg CJC-1295 and 5 mg Ipamorelin. A vial labeled 10 mg CJC-1295 plus 10 mg Ipamorelin would contain 20 mg total. Those two labels produce very different syringe-unit math, even if both are casually described as a 10 mg CJC/Ipamorelin vial. Step 3: Choose the Reconstitution Volume The amount of bacteriostatic water changes concentration. Adding 1 mL creates a more concentrated vial than adding 2 mL. The total peptide amount does not change; only the number of syringe units needed to represent a given research amount changes. For many 5 mg or 10 mg research vials, 1 mL to 2 mL is a common calculator range because it keeps syringe measurements readable. Higher-strength blends often become easier for beginners to measure with 2 mL because the per-unit concentration is less compressed. Use the Bac Water Calculator first if the mixing step is the confusing part. Step 4: Calculate U-100 Syringe Units On a U-100 insulin syringe, 100 units equals 1 mL, 50 units equals 0.5 mL, and 10 units equals 0.1 mL. Units are volume markings. They do not mean 100 mcg, 100 mg, or 100 anything unless the vial concentration makes that true. The formula is: desired research amount divided by concentration per unit equals units to draw. If the vial concentration is 50 mcg per unit and the modeled amount is 200 mcg total blend, the draw is 4 units. If the concentration is 100 mcg per unit, the same 200 mcg total blend is 2 units. CJC-1295 + Ipamorelin Blend Table Vial Setup Concentration Amount Per Unit Example: 200 mcg Total Blend 10 mg total blend + 1 mL water 10,000 mcg/mL 100 mcg total blend 2 units 10 mg total blend + 2 mL water 5,000 mcg/mL 50 mcg total blend 4 units 5 mg total blend + 2 mL water 2,500 mcg/mL 25 mcg total blend 8 units This table assumes the vial amount is total blend amount. If the label lists separate compound amounts, calculate the total vial amount first, then calculate the per-compound share based on the ratio. Separate Vials vs Combo Vials Separate CJC-1295 and Ipamorelin vials are easier to interpret because each vial has one compound and one concentration. The tradeoff is that the researcher must calculate two draw amounts and combine interpretation carefully. Combo vials are simpler to buy and handle, but they force the blend ratio to stay fixed. For a 1:1 combo, every draw contains equal parts of both compounds. That can be convenient when the research plan uses equal amounts. It is less flexible if a protocol needs different CJC-1295 and Ipamorelin amounts. Researchers comparing supplier formats can review the CJC-1295 + Ipamorelin combo product page , the CJC-1295 product page , and the Ipamorelin product page . Timing and Fasting Context Search results for this topic often discuss bedtime timing, empty-stomach timing, and daily pulse timing. That content usually comes from clinic-style protocols or community protocol writeups, not from FDA-approved instructions for these research compounds. CJC-1295 and Ipamorelin are not approved prescription therapies. From a research-design standpoint, timing matters because GH secretion is pulsatile and influenced by food intake, sleep cycles, glucose, and endogenous somatostatin signaling. If a study is trying to measure GH pulse effects, timing should be standardized across observations rather than improvised from internet dosage charts. Common Mistakes to Avoid The first mistake is treating a 10 mg blend as 10 mg of each compound without checking the label. The second is assuming that 10 syringe units always equals the same peptide amount. The third is mixing CJC-1295 DAC and No DAC discussions as though they have the same duration. The fourth mistake is forgetting that reconstitution changes concentration but not total peptide amount. Adding more bacteriostatic water does not weaken the vial in total; it spreads the same peptide across more liquid. That usually makes each syringe unit contain fewer micrograms. How to Use the PeptideStack Calculator Use the Peptide Calculator after you know three inputs: vial strength in mg, bacteriostatic water added in mL, and desired research amount in mcg. For a blend, enter the total blend strength if you want total blend units, then interpret per-compound amounts according to the vial ratio. If the starting question is simply "how much BAC water should I add?", use the Bac Water Calculator first. If the question is "how many syringe units represent this amount after mixing?", use the peptide calculator. Keeping those two steps separate prevents most beginner math errors. Quality Checks Before Any Calculation Dose math is only useful when the vial label is accurate. Before calculating CJC-1295 and Ipamorelin units, verify the compound identity, total milligrams, batch COA, purity documentation, and whether the vial is a blend or a single compound. A calculator cannot correct a mislabeled or underfilled vial. For broader quality context, our CJC-1295/Ipamorelin vs HGH guide explains why secretagogue research is different from exogenous growth hormone research, and our research peptide safety guide covers contamination, COA, and vendor-screening risks. Frequently Asked Questions How do you dose CJC-1295 and Ipamorelin? For research math, identify the vial strength, confirm whether it is a blend or separate compound vial, add the bacteriostatic water volume, and calculate U-100 syringe units from the resulting concentration. PeptideStack does not provide personal dosing instructions. How many units is CJC-1295 and Ipamorelin? Units depend on concentration. A 10 mg total blend mixed with 2 mL water equals 50 mcg total blend per U-100 syringe unit. A 200 mcg total blend example would be 4 units in that setup. Is CJC-1295 No DAC different from CJC-1295 with DAC? Yes. CJC-1295 No DAC is shorter-acting and commonly discussed with Ipamorelin in pulse-style research. CJC-1295 with DAC is longer-acting because of albumin-binding design. They should not be treated as interchangeable. Can I use one calculator for a CJC-1295 + Ipamorelin blend? Yes, if you enter the total blend strength and understand the ratio. For a 1:1 blend, half of the total calculated amount is CJC-1295 and half is Ipamorelin. For separate vials, calculate each vial separately. Are CJC-1295 and Ipamorelin FDA-approved? No. Neither CJC-1295 nor Ipamorelin is FDA-approved for any therapeutic indication. They are discussed on PeptideStack as research compounds, not as medications or human-use recommendations. References Teichman SL, et al. Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295. J Clin Endocrinol Metab . 2006;91(3):799-805. PubMed Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol . 1998;139(5):552-61. PubMed Sigalos JT, Pastuszak AW. The Safety and Efficacy of Growth Hormone Secretagogues. Sex Med Rev . 2018;6(1):45-53. PubMed Ionescu M, Frohman LA. Pulsatile secretion of growth hormone persists during continuous stimulation by CJC-1295. J Clin Endocrinol Metab . 2006;91(12):4792-7. PubMed Disclaimer: This article is for informational and educational purposes only. CJC-1295 and Ipamorelin are research compounds not approved by the FDA for any indication. This guide explains calculator math and research context only. It is not medical advice, dosing guidance, or a recommendation for human use. PeptideStack does not sell, prescribe, compound, or manufacture peptides. Some links may be affiliate links. PeptideStack page context: visitors can use the header navigation to reach the product catalog, blog, calculators, supplier pages, discount-code pages, contact page, legal policies, shipping policy, refund policy, privacy policy, terms, and research disclaimer. The site is organized around research peptide education, supplier transparency, product comparison, vendor review content, discount-code tracking, and calculator tools for reconstitution or unit conversion research planning. PeptideStack separates research-use-only peptide information from FDA-approved medication and licensed telehealth pathways. Research peptide pages are informational and are not medical advice, prescription guidance, dosing instructions, treatment recommendations, or instructions for human consumption. Many pages include affiliate disclosures because PeptideStack may earn a commission when visitors click external supplier or telehealth links. That commission does not change the price paid by visitors and does not mean PeptideStack manufactures, sells, distributes, compounds, or ships peptides or medications. Supplier and product pages should be evaluated for third-party testing, batch-specific certificates of analysis, named laboratory verification, transparent pricing, realistic delivery expectations, payment security, refund policies, support quality, and consistent research-use-only labeling. Blog pages connect related guides, comparison articles, FDA approval status explainers, safety context, legality resources, product pages, vendor reviews, and calculator tools so visitors can keep researching without relying on a single supplier claim. Calculator pages are educational tools for laboratory planning and should be cross-checked against professional protocols, institutional requirements, and applicable laws. Legal and disclaimer pages explain the boundaries of PeptideStack content and the responsibility of visitors who evaluate third-party vendors. The rendered interface may add interactive details such as mobile navigation labels, product tabs, share buttons, related article cards, disclosure boxes, call-to-action buttons, vendor selectors, copy-code controls, email-code forms, footer navigation, and status labels. The static HTML fallback includes this context so the same page purpose is understandable before the JavaScript application finishes loading. Visitors should treat PeptideStack as a research and comparison starting point. Final supplier evaluation should include direct review of the external vendor website, current product availability, checkout terms, applicable laws, institutional requirements, and any third-party laboratory documentation available for the exact product or batch being considered. Footer resources repeat important sitewide context: PeptideStack is independent, affiliate-supported, research-focused, and not a pharmacy or manufacturer. Pages may include links to the iOS app, calculators, blog hubs, product hubs, supplier comparisons, support contact, and policy documents. This repeated context is intentionally available in the raw HTML for crawlers that inspect a page before executing the React bundle. Raw HTML also includes page summaries for mobile crawlers using JavaScript rendering, desktop crawlers comparing source to rendered output, accessibility tools, and no-script visitors. The fallback is replaced by the React app in normal browsers but keeps the source document aligned with the visible page topic. This fallback keeps source HTML and rendered HTML closer for crawl diagnostics and SEO audits across crawled pages, routes, reports, and recrawls.